Table 2.

Associations of site-specific BMD^* to hematopoietic cell types at visit 3, N=2571

	Anemia	Low Platelets	WBC subtype
			neutrophils		lymphocytes		monocytes
			low	high	low	high	low	high
Femoral neck
Age & Site adj.	1.02 (0.87, 1.20)	1.06 (0.93, 1.19)	1.01 (0.91, 1.12)	1.14 (1.03, 1.27)	1.01 (0.91, 1.12)	0.88 (0.80, 0.97)	1.13 (1.02, 1.25)	0.99 (0.89, 1.09)
MTV adj.**	0.92 (0.78, 1.09)	1.02 (0.90, 1.17)	0.93 (0.83, 1.04)	1.12 (1.00, 1.25)	0.95 (0.85, 1.07)	0.92 (0.83, 1.02)	1.05 (0.94, 1.18)	0.98 (0.88, 1.09)
Total hip
Age & Site adj.	1.13 (0.96, 1.33)	1.07 (0.94, 1.21)	1.10 (0.99, 1.22)	1.08 (0.97, 1.20)	1.04 (0.94, 1.16)	0.89 (0.80, 0.98)	1.23 (1.11, 1.37)	1.01 (0.91, 1.12)
MTV adj.**	1.02 (0.86, 1.22)	1.02 (0.89, 1.17)	1.01 (0.90, 1,13)	1.05 (0.93, 1.17)	0.99 (0.88, 1.10)	0.93 (0.83, 1.04)	1.15 (1.02, 1.29)	1.01 (0.90, 1.13)
Lumbar Spine
Age & Site adj.	0.89 (0.76, 1.04)	1.03 (0.91, 1.17)	1.04 (0.94, 1.15)	0.98 (0.89, 1.09)	1.00 (0.90, 1.11)	0.93 (0.84, 1.03)	1.14 (1.02, 1.27)	1.04 (0.94, 1.16)
MTV adj.**	0.86 (0.74, 1.00)	1.01 (0.89, 1.15)	0.99 (0.89, 1.10)	0.98 (0.88, 1.09)	0.96 (0.86, 1.07)	0.96 (0.86, 1.07)	1.08 (0.97, 1.21)	1.05 (0.94, 1.17)

^*OR and 95% CI per 1SD decrease of BMD

^**Adjusted for age, site, BMI, smoking status, alcohol use, physical activity, history of cancer, self-reported health, corticosteroid use, and thiazide use.